Efficacy of Single-Dose Ivermectin on Virologic and Clinical Recovery in COVID-19: A Randomized Controlled Trial

Efficacy of Single-Dose Ivermectin on Virologic and Clinical Recovery in COVID-19: A Randomized Controlled Trial

Background: Coronavirus disease 2019 (COVID-19) pandemic mounts an ever increasing challenge on healthcare resources. Ivermectin shows promise in in vitro studies on coronavirus, but there are few prospective trials on currently approved dosage recommendation for the treatment of COVID-19. Aims: To...

Full description

Bibliographic Details
Main Authors: Romit Saxena, Muthu Rajanagam, Urmila Jhamb, Vikas Manchanda, Sonal Saxena, Pallavi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:MAMC Journal of Medical Sciences
Subjects:
coronavirus disease
randomized controlled trial
rt-pcr
Online Access:http://www.mamcjms.in/article.asp?issn=2394-7438;year=2021;volume=7;issue=2;spage=109;epage=114;aulast=Saxena

Internet

http://www.mamcjms.in/article.asp?issn=2394-7438;year=2021;volume=7;issue=2;spage=109;epage=114;aulast=Saxena

Similar Items